Current and Emerging Therapies for IgE-Mediated Food Allergy

被引：0
作者：
Robbie D. Pesek
Stacie M. Jones
机构：
[1] University of Arkansas for Medical Sciences and Arkansas Children’s Hospital,Division of Allergy/Immunology, Department of Pediatrics
来源：
Current Allergy and Asthma Reports | 2016年 / 16卷
关键词：
Oral immunotherapy; OIT; Sublingual immunotherapy; SLIT; Omalizumab; Epicutaneous immunotherapy; EPIT; Food allergy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Food allergies are a growing clinical problem leading to increased health care utilization and decreases in patient quality of life. Current treatment recommendations include strict dietary avoidance of the offending food as well as use of self-injectable epinephrine in case of accidental exposure with allergic reaction. Although many individuals will eventually outgrow their food allergies, a substantial number will not. Significant effort has been made to find novel treatments that protect patients from food-triggered reactions as well as to develop immune-modulating therapies that could lead to tolerance. In this review, three therapies that have shown the most promise for the treatment of food allergies are highlighted: oral immunotherapy, sublingual immunotherapy, and epicutaneous immunotherapy.
引用
收藏
相关论文
共 397 条
  • [21] Quirce S(2013)Long-term follow-up of oral immunotherapy for cow’s milk allergy J Allergy Clin Immunol 3 737-1205
  • [22] Fleischer DM(2012)Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children Clin Exp Allergy 42 1197-134
  • [23] Perry TT(2013)Peanut oral immuotherapy modifies IgE and IgG4 response to major peanut allergens J Allergy Clin Immunol 131 128-1638
  • [24] Atkins D(2015)Changes in peanut-specific T-cell clonotype with oral immunotherapy J Allergy Clin Immunol 135 1636-300
  • [25] Wood RA(2009)Clinical efficacy and immune regulation with peanut oral immunotherapy J Allergy Clin Immunol 124 292-510
  • [26] Burks AW(2014)Peanut oral immunotherapy results in increased antigen-induced regulator T-cell function and hypomethylation of forkhead box protein 3 (FOXP3) J Allergy Clin Immunol 133 500-1292
  • [27] Jones SM(2015)Suppression of the immunologic response to peanut during oral immunotherapy is often transient J Allergy Clin Immunol 135 1283-450
  • [28] Bock SA(2010)Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance Ann Allergy Asthma Immunol 105 444-1843
  • [29] Munoz-Furlong A(2015)Early sustained unresponsiveness after short-course egg oral immunotherapy: a randomized controlled study in egg-allergic children Clin Exp Allergy 45 1833-962
  • [30] Sampson HA(2015)High IgE levels to α-lactalbumin, β-lactoglobulin, and casein predict less successful cow’s milk oral immunotherapy Allergy 70 955-291
12345678910